V

Vertex Pharmaceuticals

Develops therapies for serious genetic diseases

DMPK Bioanalysis Intern

Regulatory & Quality (Life Sciences)Posted on Nov 13
Internship · Summer 2027Boston, MA, USA

About the Job

Requirements

  • Currently enrolled in a bachelor's or master's degree program in biochemistry, biology, biotechnology, chemistry, pharmacology, or a related life-sciences field.
  • At least one laboratory course or research experience involving biochemical or biological experiments is expected; no prior industry experience is required.
  • Able to perform basic laboratory techniques, including accurate pipetting, preparing solutions, and serial dilutions.
  • Foundational understanding of protein–ligand interactions, assay controls, and basic data analysis.
  • Able to record and analyze experimental data using Microsoft Excel or GraphPad Prism.
  • Legal authorization to work in the United States, now and in the future.
  • Must be enrolled in an advanced degree program if graduating before May 2027.
  • Available to work full-time, 40 hours per week from May through August 2027.

Responsibilities

  • Support the development and optimization of a ligand-binding assay.
  • Plan and conduct experiments with guidance from the bioanalytical team.
  • Evaluate assay performance, including sensitivity, precision, and reproducibility.
  • Analyze results, troubleshoot technical challenges, and recommend next steps.
  • Document methods, experiments, and results in accordance with relevant bioanalytical guidelines and Vertex documentation policies.
  • Present findings and progress updates to the team.

Desired Qualifications

  • Familiarity with ligand-binding assays is helpful but not required.
  • Experience with Meso Scale Discovery platforms is a plus.

About the Company

Vertex Pharmaceuticals

Develops therapies for serious genetic diseases

Vertex Pharmaceuticals develops medicines for serious diseases, with a focus on cystic fibrosis. It conducts extensive research and partners with other biotech firms to discover and develop new therapies, including ex vivo engineered cell treatments. Its products, such as ivacaftor, treat cystic fibrosis and other therapies undergo clinical testing to expand the pipeline. Revenue comes from selling approved drugs and from licensing and collaboration agreements. The company distinguishes itself through deep R&D investment, strategic partnerships, and a global reach aimed at addressing unmet medical needs. The overall goal is to bring effective new drugs to patients worldwide and improve outcomes and quality of life.

Company size
5,001-10,000
Company stage
IPO
Headquarters
Boston, MA
Founded
1989

Recently Posted Jobs

Explore more opportunities at Vertex Pharmaceuticals

See more jobs